Leslie Harrold, MD, MPH

VP, Global Head of Real World Science and Strategy
CorEvitas, LLC

Poster(s):

• (A-177) An Alternative to Non-Responder Imputation for Study Participants with Missing Outcomes in Single-Arm Drug Effectiveness Studies: A Case Study in the CorEvitas Psoriasis Registry
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-148) Beyond Comparison: Target Trial Emulation (TTE) Principles Strengthen Observational Single-Arm (SA) Effectiveness Studies
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-175) Interpretable Machine Learning Models: Describing Treatment Patterns of Healthcare Providers Selecting Rheumatoid Arthritis Therapies to Evaluate Treatment Policies
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-149) Longitudinal, Regulatory-Grade Registry Data Can Be Used to Emulate a Target Trial: An Application on Evaluating Treatments for Plaque Psoriasis
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-150) Review of Post-Authorization Safety Studies Submitted to the HMA-EMA Catalogue of RWD Studies Evaluating Cancer as an Outcome
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET